Parameter | Number of patient | Percent (%) | |
---|---|---|---|
Age (Mean, range) | 45.2 ± 11.9, (29–72) | ||
 | ≤45 | 52 | 58.4 |
 | >45 | 37 | 41.6 |
Histology | |||
 | SCCa | 75 | 84.3 % |
 | ADb | 12 | 13.5 % |
 | ASCc | 2 | 2.2 % |
Grade | |||
 | 1 | 30 | 33.7 |
 | 2 | 46 | 51.7 |
 | 3 | 13 | 14.6 |
Tumor width (Mean, range) | 12.5 ± 9.1, (3–35) | ||
 | ≤20 mm | 69 | 77.5 |
 | >20 mm | 20 | 22.5 |
Stromal invasion depth (Mean, range) | 5.6 ± 3.9, (2–21) | ||
 | ≤5 mm | 66 | 74.2 |
 | >5 mm | 23 | 25.8 |
LVSId | |||
 | + | 22 | 24.7 |
 | - | 67 | 75.3 |
Positive margin in hysterectomy specimens | 3 | 3.4 | |
 | Vaginal invasion | 1 | 1.1 |
 | Parametrial invasion | 2 | 2.2 |
Lymphadenectomy | |||
 | + | 76 | 85.4 |
 | - | 13 | 14.6 |
LNMe | 6 | 7.9 | |
 | Pelvic | 6 | 7.9 |
 | Para-aortic | 1 | 1.3 |
Adjuvant therapy | |||
 | RTf | 36 | 40.4 |
 | CTg | 26 | 29.2 |
 | Observation | 48 | 53.9 |
Follow-up (Month, range) | 52.7 ± 27.2, (7–120) | ||
Relapse | 4 | 4.5 | |
Status at last contact | |||
 | NEDi | 85 | 95.5 |
 | AWDj | 1 | 1.1 |
 | DODk | 3 | 3.4 |
5-year RFSl (%) | 93.9 | ||
5- year OSm (%) | 94.7 |